Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review

Brain Research Reviews

Volumn 62, Issue 1, 2009, Pages 71-82

  England, Timothy J ^a   Gibson, Claire L ^b   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

G CSF; Granulocyte colony stimulating factor; Ischaemic stroke

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DEATH; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; LOCOMOTION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 70449672355     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2009.09.002     Document Type: Review

References (61)

1. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., Lois C., Morrison S.J., and Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
2. Bath P.M., and Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst. Rev. 3 (2006) CD005207
3. Bath P.M., Iddenden R., Bath F.J., Orgogozo J.M., and Tirilazad International Steering Committee. Tirilazad for acute ischaemic stroke. Cochrane Database Syst. Rev. (2001) CD002087
4. Chen, S.L., Zhang, C., Huang, W., Yao, X.L., 2005. [Effects of granulocyte colony-stimulating factor on focal cerebral ischemia-reperfusion injury in rats]. Di Yi Junyi Daxue Xuebao 25, 503-7.
5. Crain B.J., Tran S.D., and Mezey E. Transplanted human bone marrow cells generate new brain cells. J. Neurol. Sci. 233 (2005) 121-123
6. Crossley N.A., Sena E., Goehler J., Horn J., van der Worp B., Bath P.M.B., Macleod M., and Dirnagl U. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke 39 (2008) 929-934
7. del Zoppo G.J. Stroke and neurovascular protection. N. Engl. J. Med. 354 (2006) 553-555
8. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
9. England T., Martin P., and Bath P.M. Stem cells for enhancing recovery after stroke: a review. Int. J. Stroke 4 (2009) 101-110
10. Fisher M., Feuerstein G., Howells D.W., Hurn P.D., Kent T.A., Savitz S.I., Lo E.H., and Group S. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40 (2009) 2244-2250
11. Gibson C.L., Bath P.M., and Murphy S.P. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25 (2005) 431-439
12. Gibson C.L., Jones N.C., Prior M.J., Bath P.M., and Murphy S.P. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 64 (2005) 763-769
13. Gibson C.L., Gray L.J., Murphy S.P., and Bath P.M. Estrogens and experimental ischemic stroke: a systematic review. J. Cereb. Blood Flow Metab. 26 (2006) 1103-1113
14. Han J.L., Kollmar R., Tobyas B., and Schwab S. Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke. Neurosci. Lett. 432 (2008) 167-169
15. Hasselblatt M., Jeibmann A., Riesmeier B., Maintz D., and Schabitz W.R. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol. 113 (2007) 45-51
16. Hermann D.M., and Kilic E. Therapeutic potential and possible risks of pleiotropic growth factors in ischemic stroke. Stroke 39 (2008) e182 author reply e183
17. Hokari, M., Kuroda, S., Chiba, Y., Maruichi, K., Iwasaki, Y., 2009. Synergistic effects of granulocyte-colony stimulating factor on bone marrow stromal cell transplantation for mice cerebral infarct. Cytokine 46, 260-266.
18. Jendelova P., Herynek V., Urdzikova L., Glogarova K., Rahmatova S., Fales I., Andersson B., Prochazka P., Zamecnik J., Eckschlager T., Kobylka P., Hajek M., and Sykova E. Magnetic resonance tracking of human CD34+ progenitor cells separated by means of immunomagnetic selection and transplanted into injured rat brain. Cell Transplant. 14 (2005) 173-182
19. Kawada H., Takizawa S., Takanashi T., Morita Y., Fujita J., Fukuda K., Takagi S., Okano H., Ando K., and Hotta T. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113 (2006) 701-710
20. Kim, B.R., Shim, J.W., Sung, D.K., Kim, S.S., Jeon, G.W., Kim, M.J., Chang, Y.S., Park, W.S., Choi, E.S., 2008. Granulocyte stimulating factor attenuates hypoxic-ischemic brain injury by inhibiting apoptosis in neonatal rats. Yonsei Med. J. 49, 836-42.
21. Kollmar R., Henninger N., Urbanek C., and Schwab S. G-CSF and rt-PA for the treatment of experimental embolic stroke. Cerebrovasc. Dis. 23 (2007) 23
22. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., Mochizuki H., Mizuno Y., and Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J. Cereb. Blood Flow Metab. 26 (2006) 402-413
23. Lan X., Qu H., Yao W., and Zhang C. Granulocyte-colony stimulating factor inhibits neuronal apoptosis in a rat model of diabetic cerebral ischemia. Tohoku J. Exp. Med. 216 (2008) 117-126
24. Lee S.T., Chu K., Jung K.H., Ko S.Y., Kim E.H., Sinn D.I., Lee Y.S., Lo E.H., Kim M., and Roh J.K. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 1058 (2005) 120-128
25. Lees K.R., and Muir K.W. Excitatory amino acid antagonists for acute stroke (Cochrane Review). The Cochrane Library (2002), Update Software, Oxford Vol.
26. Macleod M.R., Fisher M., O'Collins V., Sena E.S., Dirnagl U., Bath P.M., Buchan A., van der Worp H.B., Traystman R., Minematsu K., Donnan G.A., and Howells D.W. Good laboratory practice: preventing introduction of bias at the bench. Stroke 40 (2009) e50-e52
27. Matchett G.A., Calinisan J.B., Matchett G.C., Martin R.D., and Zhang J.H. The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats. Brain Res. 1136 (2007) 200-207
28. Minnerup J., Heidrich J., Wellmann J., Rogalewski A., Schneider A., and Schabitz W.R. Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke 39 (2008) 1855-1861
29. Morita, Y., Takizawa, S., Kamiguchi, H., Uesugi, T., Kawada, H., Takagi, S., 2007. Administration of hematopoietic cytokines increases the expression of anti-inflammatory cytokine (IL-10) mRNA in the subacute phase after stroke. Neurosci. Res. 58, 356-360.
30. Muller, H.D., Neder, A., Sommer, C., Schabitz, W.R., 2009. Different postischemic protein expression of the GABA(A) receptor alpha2 subunit and the plasticity-associated protein MAP1B after treatment with BDNF versus G-CSF in the rat brain. Restor. Neurol. Neurosci. 27, 27-39.
31. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H., et al. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319 (1986) 415-418
32. Schabitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., Sommer C., and Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34 (2003) 745-751
33. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., and Schabitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115 (2005) 2083-2098
34. Schneider A., Wysocki R., Pitzer C., Kruger C., Laage R., Schwab S., Bach A., and Schabitz W.R. An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Bio. 4 (2006) 36
35. Sehara Y., Hayashi T., Deguchi K., Zhang H., Tsuchiya A., Yamashita T., Lukic V., Nagai M., Kamiya T., and Abe K. Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats. J. Neurosci. Res. 85 (2007) 2167-2174
36. Sehara Y., Hayashi T., Deguchi K., Zhang H., Tsuchiya A., Yamashita T., Lukic V., Nagai M., Kamiya T., and Abe K. Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res. 1151 (2007) 142-149
37. Sehara, Y., Hayashi, T., Deguchi, K., Zhang, H., Tsuchiya, A., Yamashita, T., Lukic, V., Nagai, M., Kamiya, T., Abe, K., 2007c. Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res. 1151, 142-149.
38. Sena E., van der Worp H.B., Howells D., and Macleod M. How can we improve the pre-clinical development of drugs for stroke?. Trends Neurosci. 30 (2007) 433-439
39. Sevimli S., Diederich K., Strecker J.K., Schilling M., Klocke R., Nikol S., Kirsch F., Schneider A., and Schabitz W.R. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp. Neurol. 217 (2009) 328-335
40. Shuaib A., Lees K.R., Lyden P., Grotta J., Davalos A., Davis S.M., Diener H.C., Ashwood T., Wasiewski W.W., Emeribe U., and Investigators S.I.T. NXY-059 for the treatment of acute ischemic stroke. N. Engl. J. Med. 357 (2007) 562-571
41. Shyu W.C., Lin S.Z., Yang H.I., Tzeng Y.S., Pang C.Y., Yen P.S., and Li H. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 110 (2004) 1847-1854
42. Shyu W.C., Lin S.Z., Yang H.I., Tzeng Y.S., Pang C.Y., Yen P.S., and Li H. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells [see comment]. Circulation 110 (2004) 1847-1854
43. Shyu W.C., Lin S.Z., Lee C.C., Liu D.D., and Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 174 (2006) 927-933
44. Six I., Gasan G., Mura E., and Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur. J. Pharmacol. 458 (2003) 327-328
45. Solaroglu I., Tsubokawa T., Cahill J., and Zhang J.H. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 143 (2006) 965-974
46. Solaroglu I., Cahill J., Tsubokawa T., Beskonakli E., and Zhang J.H. Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol. Res. 31 (2009) 167-172
47. Sprigg N., and Bath P.M.B. Colony stimulating factors (blood growth factors) are promising but unproven for treating stroke. Stroke 38 (2007) 1997-1998
48. Sprigg N., Bath P.M., Zhao L., Willmot M.R., Gray L.J., Walker M.F., Dennis M.S., and Russell N. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 37 (2006) 2979-2983
49. STAIR. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30 (1999) 2752-2758
50. Sykova E., and Jendelova P. Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann. N. Y. Acad. Sci. 1049 (2005) 146-160
51. Taguchi A., Wen Z., Myojin K., Yoshihara T., Nakagomi T., Nakayama D., Tanaka H., Soma T., Stern D.M., Naritomi H., and Matsuyama T. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur. J. Neurosci. 26 (2007) 126-133
52. Toth Z.E., Leker R.R., Shahar T., Pastorino S., Szalayova I., Asemenew B., Key S., Parmelee A., Mayer B., Nemeth K., Bratincsak A., and Mezey E. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood 111 (2008) 5544-5552
53. Vellenga E., Rambaldi A., Ernst T.J., Ostapovicz D., and Griffin J.D. Independent regulation of M-CSF and G-CSF gene expression in human monocytes. Blood 71 (1988) 1529-1532
54. Wardlaw J.M., del Zoppo G., and Yamaguchi T. Thrombolysis for acute ischaemic stroke (Cochrane Review). The Cochrane Library (2002), Update Software, Oxford Vol.
55. Willmot M., Gibson C., Gray L., Murphy S., and Bath P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic. Biol. Med. 39 (2005) 412-425
56. Yanqing Z., Yu-Min L., Jian Q., Bao-Guo X., and Chuan-Zhen L. Fibronectin and neuroprotective effect of granulocyte colony-stimulating factor in focal cerebral ischemia. Brain Res. 1098 (2006) 161-169
57. Yata, K., Matchett, G.A., Tsubokawa, T., Tang, J., Kanamaru, K., Zhang, J.H., 2007. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res. 1145, 227-238.
58. Zhao L.R., Berra H.H., Duan W.M., Singhal S., Mehta J., Apkarian A.V., and Kessler J.A. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke 38 (2007) 2804-2811
59. Zhao L.R., Singhal S., Duan W.M., Mehta J., and Kessler J.A. Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke 38 (2007) 2584-2591
60. Zsebo K.M., Yuschenkoff V.N., Schiffer S., Chang D., McCall E., Dinarello C.A., Brown M.A., Altrock B., and Bagby Jr. G.C. Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 71 (1988) 99-103
61. Zucali J.R., Dinarello C.A., Oblon D.J., Gross M.A., Anderson L., and Weiner R.S. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J. Clin. Invest. 77 (1986) 1857-1863